
#MedTwitter #GITwitter ✳️Therapeutic Endoscopist . ✳️Passionate about Magnifying Endoscopy and ESD (thanks to my Advanced Clinical Training in 🇯🇵)✳️
Joined June 2018
- Tweets3.2K
- Following1.6K
- Followers2.4K
- Likes17.2K
Deepak Madhu retweeted
Don’t try this at home! ☺️
EUS-CDS in CBD <15 mm.
Honoured to be part of this international collaboration @GIE_Journal
⚠️ 10-mm LAMS in small CBDs. Feasible in carefully selected patients, but best left to expert centres with the necessary expertise
pubmed.ncbi.nlm.nih.gov/4298…
Deepak Madhu retweeted
PARTO much better than EUS COIL in gastric varices.
Award winning abstract presentation by @JustSagnik @drshalimar @DrLakhtakia @miNitinjagtap @AASLDtweets #LiverX #TLM26
Deepak Madhu retweeted
Deepu: Guys! We made a wearable that can track your brain activity in real time! Just place it on your temple.
Doctors: Wow! Damn cool bro. Show us how it works! We are interested!
Deepu: Ehhh...why you raging!!?? It's actually a fitness tracker.
Doctors: Oh! That's ok. We anyway need one from India! All the ones now are by the West! Go India! How does it stack up to the current cheaper validated wearables though?
Deepu:
Deepak Madhu retweeted
Claims made by Science Team and founder Deepinder Goyal about their wearable - Temple Device - on their website, podcasts, media interviews and special events before the product is shipped out for 85000/- INR - and proof for those claims.
Claim1 : Real-Time Cerebral Blood Flow Tracking -
The device claims to continuously monitor blood flow and oxygenation inside the brain—a metric they brand as "BrainFlow"—using light-based optical sensors placed against the skin near the temporal artery.
PROOF - ZERO.
Claim 2: Biological Entropy Monitoring - The device outputs a proprietary "Entropy Score" ranging from 1 to 250. The company claims this score (which remain absolutely not validated) quantifies the body's real-time metabolic and sympathetic strain—essentially measuring "how hard the body is working to shed heat" and manage stress, sleep, or recovery.
PROOF - ZERO.
Claim 3: Superior Heart Rate Tracking Accuracy - The manufacturer claims that the Temple device is the most accurate heart rate tracker on the market, outperforming flagship wrist-based wearables even during high-intensity training (Zone 4 & 5 exercises).
PROOF - ZERO.
Claim 4: Insights into Longevity and Aging - The tool is marketed to explore the "Gravity Aging Hypothesis". The manufacturer implies that tracking changes in brain blood flow can help users manage physiological stress, optimize lifestyle choices (like hydration and sleep), and track indicators linked to long-term cognitive health and aging.
PROOF - ZERO.
WHAT CLAIMS ARE CURRENTLY PROVEN FOR TEMPLE DEVICE AS PER NON-PEER REVIEWED PRE-PRINTS?
- Temple device can sense flushing and increased blood flow to the skin of the temple region and scalp in people who are active. THAT IS IT. ABSOLUTELY NOTHING TO DO WITH THE ABOVE CLAIMS or BRAIN FUNCTION.
Deepak Madhu retweeted
1/5
I built Kerala Atlas
Pick any place in Kerala — a district, taluk, etc- circle, or a shape you draw — and see its people, GDP, roads, rail, schools, & hospitals etc from 2011 to today.
👉 kerala-atlas.web.app
Thanks to @americakaran for sharing the original source tool.
🤖 A major milestone in medical robotics!
🇺🇸 FDA has authorized Vitestro’s Aletta® via the De Novo pathway.
The first standalone robotic device able to draw 🩸 without hands-on operator intervention. 🦾🩺
🔗 vitestro.com/aletta/
@vitestro @medcrux @Medscape @WileyHealth
Deepak Madhu retweeted
Referee corruption here is obvious #WorldCupFinal
#EggCoffee
#Vietnam
Foamy, bitter-sweet and strangely addictive.
1
1
182
Deepak Madhu retweeted
I discuss the merits and pitfalls of a recent article from University of British Columbia, Canada attempting to describe the role of @IMAIndiaOrg in policy decisions in India. @orfonline @oommen
orfonline.org/expert-speak/r…
Deepak Madhu retweeted
This will guarantee that not only that will your notes be short, but also higher likelihood people will read your note - and most importantly- actually understand/learn and provide better care to the patient ( even years later) … both EMR and AI Scribes - may save time- but tend to include a lot of irrelevant info.
Deepak Madhu retweeted
50mg rectal indomethacin = 100mg #PEP prevention?
New RCT says yes — for most patients.
But if history of #pancreatitis? Risk difference: +18.4% favoring 100 mg. @endoscopyjrnl @ESGE_news #GITwitter #ERCP #Endoscopy @ASGEendoscopy @drsridhars @drhrr
thieme-connect.com/products/…
Deepak Madhu retweeted
Colorectal ESD: my strategy for 90% of lesions youtu.be/gFSSfTJ8-YY?si=u-2b… via @YouTube
Incomplete colorectal polyp resection 🩺 can fuel recurrence 🔁 & post-colonoscopy CRC 🚨.
This scoping review 🔬 maps how to assess “complete” resection:
📚tinyurl.com/7er2khm8
#GITwitter #Endoscopy #MedTwitterek
Deepak Madhu retweeted
Replying to @DrAshokGastro @DouglasAdlerMD
Totally agree. Our fistulotomy rate is 20-30%. We do early NKF and also use primary NKF in certain ampullary morphology. Quicker procedures/low complications. NKF is not a last resort, but a technique to be adopted early for an effective cannulation
Deepak Madhu retweeted
🧫 New in JCG (May/June 2026)
Should all patients with biliary obstruction receive antibiotics before ERCP?
This meta-analysis of 11 RCTs found prophylaxis reduced infectious complications and bacteremia after ERCP.
📖 journals.lww.com/jcge/abstra…
#ERCP #Endoscopy #Biliary #JCG
This year @DDWMeeting 2026
Won @ASGEendoscopy award for top reviewer for @GIE_Journal.
Second year in a row
#GITwitter
#MedTwitter
#EndoSoMe
Thanks @BabuPMohan2 for the photo
































